FIRST AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT Dated 19 December 2019 BETWEEN GENMAB B.V. AND CUREVAC AGCollaboration and License Agreement • July 21st, 2020 • CureVac B.V. • Pharmaceutical preparations
This FIRST AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT ("First Amendment") is made the 2nd day of July 2020 ("First Amendment Effective Date"), by and between:
Dated 17 July 2020 KFW and DIEVINI HOPP BIOTECH HOLDING GMBH & CO. KG and CUREVAC B.V. (to be converted into CUREVAC N.V.) RELATIONSHIP AGREEMENTRelationship Agreement • July 21st, 2020 • CureVac B.V. • Pharmaceutical preparations
The Co-Shareholders and the Company may each be referred to herein individually as a “Party” and collectively as the “Parties”.
TERMINATION AGREEMENT between CUREVAC AG and ELI LILLY AND COMPANYEli Lilly and Company • July 21st, 2020 • CureVac B.V. • Pharmaceutical preparations
CUREVAC REAL ESTATE GMBH, a German limited liability company, having a place of business at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany (CureVac AG and CureVac Real Estate GmbH jointly “CureVac”) and
Amendment to the convertible loan agreement dated October 24, 2019 between Mr. Dietmar Hopp, Johann-Jakob-Astor-Str. 57, 69190 Walldorf also referred to as the lender and CureVac AG, Paul-Ehrlich-Straße 15, 72076 also referred to as the "borrower"CureVac B.V. • July 21st, 2020 • Pharmaceutical preparations
The Borrower intends to conduct a financing round in the short term and subsequently, after a restructuring process in which all shares of CureVac AG will be contributed to a Dutch company (CureVac NV), to conduct an initial public offering on the Nasdaq. The Borrower must maintain liquidity of at least EUR 60 million in preparation for the IPO.
Shareholders' Agreement in relation to the Parties' share portfolios in CureVac N.V. (NL-Amsterdam) between Kreditanstalt für Wiederaufbau Palmengartenstr. 5-9, 60325 Frankfurt am Main - hereinafter referred to as "Federal Investor" - on the one hand...Shareholders' Agreement • July 21st, 2020 • CureVac B.V. • Pharmaceutical preparations
